JP2020522535A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020522535A5 JP2020522535A5 JP2019567345A JP2019567345A JP2020522535A5 JP 2020522535 A5 JP2020522535 A5 JP 2020522535A5 JP 2019567345 A JP2019567345 A JP 2019567345A JP 2019567345 A JP2019567345 A JP 2019567345A JP 2020522535 A5 JP2020522535 A5 JP 2020522535A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- antibody
- seq
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023041296A JP7777096B2 (ja) | 2017-06-06 | 2023-03-15 | ミクログリアの活性化を抑制する方法 |
| JP2024231213A JP2025066722A (ja) | 2017-06-06 | 2024-12-26 | ミクログリアの活性化を抑制する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762515711P | 2017-06-06 | 2017-06-06 | |
| US62/515,711 | 2017-06-06 | ||
| PCT/US2018/036261 WO2018226833A1 (en) | 2017-06-06 | 2018-06-06 | Methods of suppressing microglial activation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023041296A Division JP7777096B2 (ja) | 2017-06-06 | 2023-03-15 | ミクログリアの活性化を抑制する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020522535A JP2020522535A (ja) | 2020-07-30 |
| JP2020522535A5 true JP2020522535A5 (https=) | 2021-05-27 |
| JP7247113B2 JP7247113B2 (ja) | 2023-03-28 |
Family
ID=64566373
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019567345A Active JP7247113B2 (ja) | 2017-06-06 | 2018-06-06 | ミクログリアの活性化を抑制する方法 |
| JP2023041296A Active JP7777096B2 (ja) | 2017-06-06 | 2023-03-15 | ミクログリアの活性化を抑制する方法 |
| JP2024231213A Pending JP2025066722A (ja) | 2017-06-06 | 2024-12-26 | ミクログリアの活性化を抑制する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023041296A Active JP7777096B2 (ja) | 2017-06-06 | 2023-03-15 | ミクログリアの活性化を抑制する方法 |
| JP2024231213A Pending JP2025066722A (ja) | 2017-06-06 | 2024-12-26 | ミクログリアの活性化を抑制する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20200165338A1 (https=) |
| EP (1) | EP3634478A4 (https=) |
| JP (3) | JP7247113B2 (https=) |
| CA (1) | CA3066353A1 (https=) |
| WO (1) | WO2018226833A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021195431A1 (en) * | 2020-03-25 | 2021-09-30 | The Brigham And Women's Hospital, Inc. | Inhaled xenon therapy in neurodegenerative disease |
| US20210353566A1 (en) * | 2020-05-12 | 2021-11-18 | Massachusetts Institute Of Technology | The use of choline supplementation as therapy for apoe4-related disorders |
| WO2021255189A1 (en) * | 2020-06-17 | 2021-12-23 | Tiziana Life Sciences, Plc | Compositions and methods for augmenting chimeric antigen receptor (car) t cell therapies |
| EP4188440A2 (en) * | 2020-07-30 | 2023-06-07 | Tiziana Life Sciences PLC | Cd-3 antibodies for the treatment of coronavirus |
| JP2024538064A (ja) * | 2021-10-14 | 2024-10-18 | ティジアーナ ライフ サイエンシズ パブリック リミティド カンパニー | ミクログリア活性化を抑制するための方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7205280B2 (en) * | 1998-03-11 | 2007-04-17 | Cognosci, Inc. | Methods of suppressing microglial activation |
| JP5139800B2 (ja) * | 2004-06-03 | 2013-02-06 | ノビミューン エスアー | 抗ｃｄ３抗体およびその使用方法 |
| AR057807A1 (es) * | 2005-09-12 | 2007-12-19 | Novimmune Sa | Formulaciones de anticuerpo anti-cd3 |
| IL264502B2 (en) * | 2016-08-29 | 2023-09-01 | Tiziana Life Sciences Plc | Anti-cd3 antibody formulations |
-
2018
- 2018-06-06 EP EP18813852.3A patent/EP3634478A4/en active Pending
- 2018-06-06 WO PCT/US2018/036261 patent/WO2018226833A1/en not_active Ceased
- 2018-06-06 US US16/619,866 patent/US20200165338A1/en not_active Abandoned
- 2018-06-06 CA CA3066353A patent/CA3066353A1/en active Pending
- 2018-06-06 JP JP2019567345A patent/JP7247113B2/ja active Active
-
2022
- 2022-03-18 US US17/698,617 patent/US20230039028A1/en active Pending
-
2023
- 2023-03-15 JP JP2023041296A patent/JP7777096B2/ja active Active
-
2024
- 2024-12-26 JP JP2024231213A patent/JP2025066722A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020522535A5 (https=) | ||
| RU2006123481A (ru) | Nogo-a-нейтрализующие иммуноглобулины для лечения неврологических заболеваний | |
| JP2019522961A5 (https=) | ||
| JP2020500538A5 (https=) | ||
| JP2013507991A5 (https=) | ||
| JP2012504634A5 (https=) | ||
| JP2020508303A5 (https=) | ||
| JP2012504955A5 (https=) | ||
| FI4045533T3 (fi) | Ihmisen monoklonaalisia vasta-aineita vakavalle akuutille koronavirus 2 -hengityselinoireyhtymälle (sars-cov-2) | |
| JP2014524748A5 (https=) | ||
| JP2009511480A5 (https=) | ||
| JP2011506483A5 (https=) | ||
| JP2017528476A5 (https=) | ||
| JP2016529229A5 (https=) | ||
| JP2011528902A5 (https=) | ||
| JP2018527000A5 (https=) | ||
| RU2010123888A (ru) | Axl-антитела | |
| JP2006522830A5 (https=) | ||
| JP2010526087A (ja) | 抗ｉｌ−５抗体を投与するための方法 | |
| CA2494008A1 (en) | Anti-myelin associated glycoprotein (mag) antibodies | |
| JP2019527194A5 (https=) | ||
| JP2017534646A5 (https=) | ||
| JP2019534003A5 (https=) | ||
| JP2017507131A5 (https=) | ||
| JP7247113B2 (ja) | ミクログリアの活性化を抑制する方法 |